Generation and gender differences in the components contributing to the diagnosis of the metabolic syndrome according to the Japanese criteria

Circulation Journal

Volumn 71, Issue 11, 2007, Pages 1734-1737

  Kobayashi, Junji ^a   Nishimura, Kouji ^b   Matoba, Munetoshi ^c   Maekawa, Nobumasa ^c   Mabuchi, Hiroshi ^a  

^a KANAZAWA UNIVERSITY GRADUATE SCHOOL OF MEDICAL SCIENCE   (Japan)

^b Ishikawa Health Service Association   (Japan)

^c National Hospital Organization   (Japan)

Author keywords

Atherosclerosis; Carotid artery; Coronary artery; Triglycerides; Visceral fat

Indexed keywords

HIGH DENSITY LIPOPROTEIN CHOLESTEROL;

ADULT; AGED; ARTICLE; BODY MASS; CONTROLLED STUDY; DIAGNOSTIC PROCEDURE; DIASTOLIC BLOOD PRESSURE; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; HYPERTENSION; JAPANESE; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; MORBIDITY; PREVALENCE; SEX DIFFERENCE;

ADULT; AGED; AGED, 80 AND OVER; AGING; BLOOD GLUCOSE; BLOOD PRESSURE; CHOLESTEROL, HDL; CROSS-SECTIONAL STUDIES; FEMALE; HUMANS; JAPAN; MALE; METABOLIC SYNDROME X; MIDDLE AGED; PREVALENCE; SEX CHARACTERISTICS; TRIGLYCERIDES;

EID: 36949039445     PISSN: 13469843     EISSN: 13474820     Source Type: Journal    
DOI: 10.1253/circj.71.1734     Document Type: Article

References (23)

1. Boyko EJ, de Courten M, Zimmet PZ, Chitson P, Tuomilehto J, Alberti KG. Features of the metabolic syndrome predict higher risk of diabetes and impaired glucose tolerance: A prospective study in Mauritius. Diabetes Care 2000; 23: 1242-1248.
2. Lorenzo C, Okoloise M, Williams K, Stern MP, Haffner SM. The metabolic syndrome as predictor of type 2 diabetes: The San Antonio Heart Study. Diabetes Care 2003; 26: 3153-3159.
3. Wang JJ, Qiao Q, Miettinen ME, Lappalainen J, Hu G, Tuomilehto J. The metabolic syndrome defined by factor analysis and incident type 2 diabetes in a Chinese population with high postprandial glucose. Diabetes Care 2004; 27: 2429-2437.
4. Ford ES. Risks for all-cause mortality, cardiovascular disease, and diabetes associated with the metabolic syndrome: A summary of the evidence. Diabetes Care 2005; 28: 1769-1778.
5. Grundy SM, Cleeman JI, Daniels SR, Donato KA, Eckel RH, Franklin BA, et al. Diagnosis and management of the metabolic syndrome: An American Heart Association/National Heart, Lung. and Blood Institute Scientific Statement. Circulation 2005; 112: 2735-2752.
6. Issa BG, Hanna FW. Insulin resistance, tlie metabolic syndrome and risk of cardiovascular disease: A complex story. Curr Opin Lipidol 2003; 14: 405-407.
7. Ferrannini E. Is insulin resistance the cause of the metabolic syndrome? Ann Med 2006; 38: 42-51.
8. Matsuzawa Y. Metabolic syndrome-definition and diagnostic criteria in Japan. J Atheroscler Thromb 2005; 12: 301.
9. Examination Committee of Criteria for 'Obesity Disease' in Japan; Japan Society for the Study of Obesity. New criteria for 'obesity disease' in Japan. Circ J 2002; 66: 987-992.
10. Ford ES, Giles WH, Dietz WH. Prevalence of tlie metabolic syndrome among US adults: Findings from the third National Health and Nutrition Examination Survey. JAMA 2002; 287: 356-359.
11. Balkau B, Charles MA, Drivsholm T, Borch-Johnsen K, Wareham N, Yudkin JS, et al. Frequency of the WHO metabolic syndrome in European cohorts, and an alternative delinition of an insulin resistance syndrome. Diabetes Metab 2002; 28: 364-376.
12. Lauenborg J, Mathiesen E, Hansen T, Glumer C, Jorgensen T, Borch-Johnsen K, et al. The prevalence of the metabolic syndrome in a Danish population of women with previous gestational diabetes mellitus is three-fold higher than in the general population. J Clin Endocrinol Metab 2005; 90: 4004-4010.
13. Arai H, Yamamoto A, Matsuzawa Y, Saito Y, Yainada N, Oikawa S, et al. Prevalence of metabolic syndrome in the general Japanese population in 2000. J Atheroscler Thromb 2006; 13: 202-208.
14. Ishizaka N, Ishizaka Y, Toda E, Hashimoto H, Nagai R, Yamakado M. Hypertension is the most common component of metabolic syndrome and the greatest contributor to carotid arteriosclerosis in apparently healthv Japanese individuals. Hypertens Res 2005; 28: 27-34.
15. Tanaka H, Shimabukuro T, Shimabukuro M. High prevalence of metabolic syndrome among men in Okinawa. J Atherosder Thromb 2005; 12: 284-288.
16. Takeuchi H, Saitoh S, Takagi S, Ohnishi H, Ohhata J, Isobe T, et al. Metabolic syndrome and cardiac disease in Japanese men: Applicability of the concept of metabolic syndrome defined by the National Cholesterol Education Program-Adult Treatment Panel III to Japanese men - the Tanno and Sobetsu Study. Hypertens Res 2005; 28: 203-208.
17. Miyatake N, Saito T, Wada J, Miyachi M, Tabata I, Matsumoto S, et al. Comparison of ventilatory threshold and exercise habits between Japanese men with and without metabolic syndrome. Diabetes Res Clin Tract 2007; 77: 314-319.
18. Ishikawa S, Kayaba K, Gotoh T, Nakamura Y, Kajii E. Metabolic syndrome and C-reactive protein in the general population: JMS Cohort Study. Circ J 2007; 71: 26-31.
19. Oda E, Watanabe K, Japanese criteria of metabolic syndrome. Circ J 2006; 70: 364.
20. Yoo TW, Sung KC, Shin HS, Kim BJ, Kim BS, Kang JH, et al. Relationship between serum uric acid concentration and insulin resistance and metabolic syndrome. Circ J 2005; 69: 928-933.
21. Zavaroni I, Mazza S, Fantuzzi M, Dall'Aglio E, Bonora E, Delsignore R, et al. Changes in insulin and lipid metabolism in males with asymptomatic hyperuricaemia. J Intern Med 1993; 234: 25-30.
22. Vuorinen-Markkola H, Yki-Jarvinen H. Hyperuricemia and insulin resistance. J Clin Endocrinol Metab 1994; 78: 25-29.
23. D'Agostino RB, Belanger AJ, Kannel WB, Cruicksliank JM. Relation of low diastolic blood pressure to coronary heart disease death in presence of myocardial infarction: The Framingham Study. BMJ 1991; 303: 385-389.